EUVIMEDEUVIMED entdecken
Crossref

Morbidities and comorbidities associated with optic nerve hypoplasia and septo‐optic‐pituitary dysplasia

Michael S Salman iD, Chelsea A Ruth, Marina S Yogendran, Lisa M Lix

Developmental Medicine & Child Neurology · 2025-07 · 67 (7) · 941-952

DOI: 10.1111/dmcn.16235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 13.01.2025. Verfasst von Michael S Salman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pediatric Neurology, Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University …. Hauptthemen laut MEDLINE: Optic Nerve Hypoplasia, Septo-Optic Dysplasia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Manitoba Center for Health Policy support fund, Children's Hospital Research Institute of Manitoba, Foundation Fighting Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To quantify optic nerve hypoplasia (ONH) and septo‐optic‐pituitary dysplasia (SOD) morbidities and comorbidities.

Method

A retrospective population‐based study with a case–control design was undertaken using administrative health data from Manitoba, Canada. Cases were 124 patients with ONH or SOD (70 males, 54 females; age range 6 months–36 years 8 months [mean 13 years, SD 7 years 2 months]) diagnosed from 1990 to 2019, matched to 620 unrelated population‐based controls (350 males, 270 females; age range 0–36 years 8 months [mean 12 years 5 months, SD 7 years 2 months]) on birth year, sex, and area of residence. Additionally, 76 cases with ONH or SOD (46 males, 30 females; age range 2 years 5 months–36 years 8 months [mean 13 years 11 months, SD 7 years 3 months]) were matched one‐to‐one with sibling controls (40 males, 36 females; age range 7 months–33 years 1 month [mean 11 years 8 months, SD 7 years 3 months]). We used χ 2 or Fisher's exact tests to test for differences in prevalence in morbidities and comorbidities between cases and controls; odds ratios (ORs) with 95% confidence intervals (CIs) were estimated. Cox proportional hazards models were used to test for differences in subgroups of cases; hazard ratios and 95% CIs were estimated.

Results

Visual impairment and visual impairment with hypopituitarism were core morbidities associated with ONH and SOD cases respectively compared to unrelated controls (OR = 58.6, 95% CI = 22.5–152.5; OR = 243.4, 95% CI = 32.9–1799.0 respectively). Developmental delay or intellectual disability (OR = 6.9, 95% CI = 3.3–14.4), autism spectrum disorder (OR = 4.0, 95% CI = 2.0–8.3), epilepsy (OR = 14.9, 95% CI = 6.1–36.5), cerebral palsy (OR = 40.9, 95% CI = 14.0–119.6), and mood or anxiety disorders (OR = 1.7, 95% CI = 1.0–2.8) were the comorbidities more common among cases with ONH and SOD. Cases matched to siblings showed similar results except for mood and anxiety disorders.

Interpretation

Visual impairment and visual impairment with hypopituitarism are the main morbidities in patients with ONH and SOD respectively, while developmental delay or intellectual disability, autism spectrum disorder, epilepsy, cerebral palsy, and mood or anxiety disorders are important comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic Nerve HypoplasiaSepto-Optic DysplasiaHumansMorbidityComorbidityMaleFemaleInfantChild, PreschoolChildAdolescentYoung AdultAdultRetrospective StudiesCase-Control StudiesHypopituitarismVision DisordersDevelopmental DisabilitiesAutism Spectrum DisorderEpilepsyCerebral PalsyMood Disorders

Autor:innen und Institutionen

  • Section of Pediatric Neurology, Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Section of Neonatology, Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

ORCID-Profile: Michael S Salman

Förderung

  • Manitoba Center for Health Policy support fund
  • Children's Hospital Research Institute of Manitoba
  • Foundation Fighting Blindness

Zitieren

APA

Salman, M. S., Ruth, C. A., Yogendran, M. S., & Lix, L. M. (2025). Morbidities and comorbidities associated with optic nerve hypoplasia and septo‐optic‐pituitary dysplasia. Developmental Medicine & Child Neurology, 67(7), 941-952. https://doi.org/10.1111/dmcn.16235

Vancouver

Salman MS, Ruth CA, Yogendran MS, Lix LM. Morbidities and comorbidities associated with optic nerve hypoplasia and septo‐optic‐pituitary dysplasia. Developmental Medicine & Child Neurology. 2025;67(7):941-952. doi:10.1111/dmcn.16235

BibTeX
@article{Salman2025,
  author = {Salman, Michael S and Ruth, Chelsea A and Yogendran, Marina S and Lix, Lisa M},
  title = {Morbidities and comorbidities associated with optic nerve hypoplasia and septo‐optic‐pituitary dysplasia},
  journal = {Developmental Medicine & Child Neurology},
  year = {2025},
  volume = {67},
  number = {7},
  pages = {941--952},
  doi = {10.1111/dmcn.16235}
}
Kostenlos starten →